National Stock Exchange of India & Abbott Laboratories
5 shared events · Importance 3 · Last updated Aug 10, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
National Stock Exchange of India: As the index administrator, NSE Indices conducted the semi-annual review, determining the changes. The rejig reflects its methodology and may influence trading volumes and index-related products.
Abbott Laboratories: Abbott Laboratories was also considered for NIFTY 50 but did not qualify. No direct impact from this review.
Aug 10, 2026 · 7 articles
Business
National Stock Exchange of India: Exchange where Dr. Reddy's shares fell 2.16% after results.
Abbott Laboratories: Central company; reported 69% profit plunge, made Rs 240 crore provision, delayed semaglutide supplies, and faces securities investigation. Shares fell sharply.
Jul 09, 2026 · 23 articles
Business
National Stock Exchange of India: The NSE will host the listing of Symbiotec Pharmalab shares, adding to its trading volumes and reinforcing its position as a primary listing venue.
Abbott Laboratories: As a listed peer, Abbott Laboratories may see valuation comparisons and investor interest spillover.
Aug 19, 2026 · 20 articles
Business
National Stock Exchange of India: Exchange where Pfizer shares are listed and traded.
Abbott Laboratories: Terminated distribution agreement with Novartis for select brands, continuing commercialization until September 30, 2026.
Sep 07, 2026 · 6 articles
Business
National Stock Exchange of India: Novartis shares traded on NSE, up 3% after the announcement.
Abbott Laboratories: Vikas Gupta previously served as CEO of Abbott Laboratories, one of India's largest pharma companies.
Jul 29, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how National Stock Exchange of India and Abbott Laboratories interact across events, view sentiment trends, and discover connected entities.
Open Dashboard